Cycloferon: how to take

Registration number: R N001049/02 dated 12/12/2007 Tradename: CYCLOFERON® (СYCLOFERON®) Dosage form: enteric-coated tablets Group name: meglumine acridone acetate

Composition of the drug Pharmacological properties Indications for use Contraindications

Directions for use and dosage Side effects Interaction with other drugs

Pharmacological properties

Pharmacodynamics

Cycloferon is a low-molecular-weight interferon inducer, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory, etc.). Cycloferon is effective against herpes viruses, influenza and other pathogens of acute respiratory diseases. It has a direct antiviral effect, suppressing viral reproduction in the early stages (days 1–5) of the infectious process, reducing the infectivity of viral offspring, leading to the formation of defective viral particles. Increases the body's nonspecific resistance to viral and bacterial infections.

Pharmacokinetics

When taking a daily dose, the maximum concentration in the blood plasma is reached after 2–3 hours, gradually decreases by the 8th hour, and after 24 hours Cycloferon is detected in trace amounts. The half-life of the drug is 4–5 hours, so its use in recommended doses does not create conditions for accumulation in the body.

Description, composition and release form

Cycloferon is considered a domestically produced medicine. It is produced in several forms:

• tablets for oral administration. Sold in packaging;
• ointment and gel, distinguished by a specific odor. Sold in tubes;
• solution in ampoules.

An antiviral drug can improve the resistance of the human body. The drug has high pharmacological activity. Used to treat viral and bacterial diseases, as well as to strengthen the immune system. Cycloferon has a broad effect. This remedy has been known for several decades. During this time, doctors and patients were able to verify its effectiveness for various diseases.

The main active ingredient is the compound acridoneacetic acid. Additional components include:

• tablets contain: polymers, cellulose, povidones, Ca salts;
• in the form of gels and ointments: meglumines, benzalkonium;
• solution: sterile water, meglumines.

Directions for use and doses

Orally once a day 30 minutes before meals, without chewing, with ½ glass of water, in age-specific dosages:

• children 4–6 years old: 150 mg (1 tablet) per dose;
• children 7–11 years old: 300–450 mg (2–3 tablets) per dose;
• adults and children over 12 years of age: 450–600 mg (3–4 tablets) per dose.

It is advisable to repeat the course 2–3 weeks after the end of the first course.

In adults:

1. When treating influenza and acute respiratory diseases, the drug is taken on days 1, 2, 4, 6, 8 (course of treatment - 20 tablets). Treatment should begin at the first symptoms of the disease. For severe flu, take six tablets on the first day. If necessary, additional symptomatic therapy is carried out (antipyretics, analgesics, expectorants).
2. For herpes infection, the drug is taken on days 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 (course of treatment - 40 tablets). Treatment is most effective when the first symptoms of the disease appear.

In children from four years of age:

1. For influenza and acute respiratory diseases, the drug is taken in age-specific doses on days 1, 2, 4, 6, 8, 11, 14, 17, 20, 23. The course of treatment ranges from 5 to 10 doses, depending on the severity of the condition and the severity of clinical symptoms.
2. For herpes infection, the drug is taken on the 1st, 2nd, 4th, 6th, 8th, 11th, 14th day of treatment. The course of treatment may vary depending on the severity of the condition and the severity of clinical symptoms.
3. For emergency nonspecific prevention of influenza and acute respiratory diseases (in direct contact with patients with influenza or acute respiratory infections of another etiology, during an influenza epidemic): on the 1st, 2nd, 4th, 6th, 8th day. Next, take a break of 72 hours (three days) and continue the course on the 11th, 14th, 17th, 20th, 23rd day. The general course is from 5 to 10 doses.

Indications for use

The drug in the form of tablets and solution can be taken for the following conditions:

• ARVI;
• herpes;
• Lyme disease;
• secondary immunodeficiency;
• candidiasis of various etiologies;
• condylomas;
• serous meningitis.

This is not the entire list of diseases for which Cycloferon helps. Only a doctor can prescribe medication after examination and diagnosis.

Children are allowed to take the product from 4 years of age. Indications for use in pediatrics:

• flu;
• hepatitis B and C;
• intestinal infections;
• acute respiratory infections.

Side effects

According to the World Health Organization, adverse effects are classified according to their frequency as follows:

– very frequent (≥ 1/10); – frequent (≥ 1/100 – < 1/10); – uncommon (≥ 1/1000 – < 1/100); – rare (≥ 1/10000 – < 1/1000); – very rare (< 1/10000); – frequency unknown (cannot be determined based on available data). Immune system disorders: very rarely - angioedema. Disorders of the skin and subcutaneous tissues: very rarely - rash, urticaria. If any of the undesirable effects indicated in the instructions get worse or you notice any other undesirable effects not listed in the instructions, tell your doctor.

Pharmacology

The mechanism of action of the drug is as follows:

• takes part in starting the process of phagocytosis;
• accelerates the production of interferon;
• has an antitumor effect;
• prevents the emergence and spread of harmful bacteria;
• eliminates inflammatory processes.

The active substance can penetrate the body's protective barriers, including the circulatory system and brain tissue. The maximum concentration of constituent elements in the blood is achieved after 2.5 hours and persists for 8 hours. The drug is endowed with two main properties - it strengthens the immune system and has an antimicrobial effect. Cycloferon also copes with various allergic and inflammatory reactions.

When used externally, local immunity is also strengthened and skin protection is created. Gels and ointments prevent viral DNA from entering the skin.

Instructions for use

The instructions for taking Cycloferon indicate standard doses. But they can be corrected after examination by a doctor and he has established an accurate diagnosis.

For an adult

The duration of the treatment course for adults is approximately 12-14 days. You can drink 2-3 tablets 1-2 times a day. It is best to take the medicine before meals. The course of treatment is determined by a specialist. The greatest results can be achieved if you start taking the drug in the initial stages of the disease.

In the case of a solution, the dose is selected for each patient individually, taking into account his condition. The course of treatment can last from 1 to 2 weeks.

For a child

Children can be prescribed the drug from the age of 4 years. A child aged 4-6 years is allowed only solutions. At the age of 7-12 years, you can drink 3 tablets per day. The duration of the treatment course is 7-14 days. The drug can also only be prescribed by a specialist.

Basic regimen for taking Cycloferon (table) for colds and flu

The regimen for taking Cycloferon was developed taking into account the characteristics of the human immune system. Cycloferon (table) should be taken once a day, half an hour before meals, with ½ glass of water. At the beginning of treatment, the tablets are taken for two days in a row (days 1, 2), after which it is necessary to take a break for one day and continue taking the drug on the fourth day of treatment. Next, Cycloferon is taken every other day (days 6 and 8 of treatment), without changing the dosage.

The tablets cannot be chewed - they are coated with a special enteric coating designed to transport the active substance through the stomach to the intestines, where the active substance is absorbed and subsequently distributed to areas affected by the viral infection. The destruction of tablets at the time of administration (crushing, resorption, chewing) leads to a decrease in the therapeutic effect.

If the next dose of Cycloferon was missed, then at the first opportunity you should continue the course of treatment according to the basic regimen, every other day, without changing the dosage.

If the necessary break between doses of the drug has not been taken, you should skip 2 days, and then continue taking Cycloferon (table) according to the schedule every other day.

Release form

Solution for intravenous and intramuscular administration 125 mg/ml. 2 ml in brown glass ampoules. A self-adhesive label is placed on the ampoule. 5 ampoules are placed in a blister pack made of polymer film. The contour blister packaging is heat-sealed with a cover film or left open. 1 blister pack together with instructions for medical use are placed in a cardboard box. To control the first opening, the side flaps of the package can be sealed with labels.

Contraindications and adverse reactions

The drug has the following contraindications:

• cirrhosis of the liver;
• pregnancy;
• breastfeeding period;
• thyroid disease;
• children under 4 years old;
• excessive sensitivity to constituent components.

Taking Cycloferon can in rare cases lead to side effects. These include:

• hyperthermia of the skin;
• allergies in the form of redness, rash and itching;
• vomiting and nausea;
• elevated temperature.

If such symptoms are found, then you should stop taking the drug and consult a doctor to select a suitable analogue.

Dosage of Cycloferon (table) for adults and children over 4 years of age

One tablet of Cycloferon contains 150 mg of the active substance (meglumine acridone acetate). The optimal therapeutic dosage of the drug is determined individually and depends on the age and weight of the person. This makes it possible to use the drug for the treatment of influenza and ARVI in both adults and children over 4 years of age.

1. For an adult, the standard dosage of the drug is 4 tablets per dose (600 mg). In case of severe flu on the first day, the dose can be increased to 6 tablets per dose.
2. Children aged 4 to 6 years are advised to take 1 tablet per dose (150 mg).
3. Children 7-11 years old are recommended to take 2-3 tablets per dose (up to 450 mg).
4. For children over 12 years of age, up to 4 tablets (up to 600 mg) are recommended.

How to use Cycloferon (tablets) for the treatment of influenza and ARVI in CHILDREN over 4 years old. More details

Why do doctors recommend using Cycloferon (table)

1. Cycloferon has a direct antiviral effect, helping to block the activity of influenza and ARVI viruses.
2. It has a wide range of antiviral activity* and is used against various influenza viruses, including influenza viruses type A (H3N2) and (H1N1) - “Hong Kong” and “swine” flu, and other pathogens of acute respiratory diseases, as well as herpes.
3. Increases the body's resistance to infectious diseases caused by influenza and ARVI viruses, as it stimulates the activity of its own immunity**.
4. Cycloferon has an anti-inflammatory effect.
5. Helps reduce the frequency, severity and duration of viral infections, including colds and flu**.
6. Cycloferon does not put additional stress on the liver and is almost completely eliminated from the body within a day. Avoiding additional stress on the liver is very important, especially in the case of prescribing antibiotics, which can be used when bacterial complications occur in combination with the main antiviral therapy.
7. Does not reduce the therapeutic effect even with frequent use**.
8. Compatible with various drugs to relieve symptoms of flu and colds (antipyretic, expectorant, analgesic, etc.).
9. Within 2-3 hours from the moment of administration, the maximum concentration of the active substance in the patient’s blood is observed and the antiviral effect of the drug begins.

Due to its properties, Cycloferon is included in the Temporary guidelines “Drug therapy of acute respiratory viral infections (ARVI) in outpatient practice during the COVID-19 epidemic” version 2 dated April 16, 2020, and also as an interferon inducer included in the Temporary guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)” version 9 dated October 26, 2020***